Very rare cases of MDS and secondary malignancies, including myeloid leukaemia have been reported in patients treated with regimens that included TMZ.
Väga harva on TMZ- ravi saanud patsientidel teatatud MDS ja sekundaarsete maliigsuste, sh müeloidse leukeemia juhtudest.